RSS

insulin

In the next 12 years, half of those with type 2 diabetes won’t be able to receive potentially life-saving insulin unless access to the drug improves, new research shows. Read more

News

Novo Nordisk, global healthcare company, has acquired all of the shares of a University of Bristol spin-out company — Ziylo — giving it full rights to a glucose blinding molecule platform to develop glucose responsive insulins. Read more

News

A brief round up of some of the latest developments in the industry, including a review into medical marijuana and a potential win for Trump in drug pricing… Read more

Opinion

A brief round-up of some of the developments in the industry including a step in the right direction for oral insulin and an overview of Alantra Pharma’s Fast 50 index… Read more

Opinion

A device that takes inspiration from a spider’s web that may be a game-changer in the control of Type 1 diabetes has been developed by researchers from Cornell University. Read more

Technology

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Phillips-Medisize has entered into an agreement with biotechnology company Dance Biopharm to develop a connected insulin inhaler. Read more

Technology

Global healthcare company, Novo Nordisk, has revealed that the US Food and Drug Administration (FDA) has approved its fast-acting mealtime insulin, Fiasp, for the improvement of glycaemic control in adults with diabetes. Read more

Technology

A potential new therapy for type I diabetes patients has been found to be safe and does not accelerate decline in β cell function — important in the production of insulin — in a recently published clinical trial. Read more

News

Amrita Banerjee, post-doctoral scholar, University of California Santa Barbara talks oral insulin and needle-free delivery of protein Read more

Opinion

Novo Nordisk has submitted a New Drug Application (NDA) for a faster-acting insulin aspart to the US Food and Drug Administration (FDA) Read more

News

EPM selects five noteworthy drugs and drug delivery developments from the past month Read more

News

Researchers have developed an intestinal patch device containing insulin that can be swallowed in a capsule Read more

News

Cambridge Consultants has won a Red Dot Design Award for its KiCoPen smart insulin pen concept Read more

News

Y. Shashidhar, partner & managing director, South Asia, Middle East & North Africa, Frost & Sullivan talks about how the local production of insulin from Novo Nordisk’s new plant in Iran could impact the pharma market Read more

Opinion

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. Read more

News

Final-year Brunel University design student Oscar Daws has come up with a streamlined device that aims to vastly improve patients’ self-management of diabetes and has been selected for a prestigious exhibition on London’s South Bank. Read more

Technology

afrezza.jpg

Copyright: MannKind Corporation

The new rapid-acting inhaled insulin therapy is for treating adults with type 1 and type 2 diabetes. Read more

The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries on 27 May 2014. Read more